Wall Street analysts predict that CRH Medical Corporation (NASDAQ:CRHM) will post $29.50 million in sales for the current quarter, according to Zacks Investment Research. Two analysts have made estimates for CRH Medical’s earnings, with estimates ranging from $28.40 million to $30.60 million. CRH Medical posted sales of $27.33 million during the same quarter last year, which would indicate a positive year-over-year growth rate of 7.9%. The business is scheduled to issue its next quarterly earnings results on Wednesday, August 7th.

On average, analysts expect that CRH Medical will report full-year sales of $129.10 million for the current year, with estimates ranging from $125.70 million to $132.30 million. For the next fiscal year, analysts expect that the business will report sales of $144.18 million, with estimates ranging from $132.40 million to $159.90 million. Zacks Investment Research’s sales averages are a mean average based on a survey of research analysts that cover CRH Medical.

CRHM traded down $0.03 on Wednesday, hitting $2.71. The company had a trading volume of 167,300 shares, compared to its average volume of 67,906. CRH Medical has a 1 year low of $2.51 and a 1 year high of $4.50. The stock’s fifty day simple moving average is $2.85.

CRH Medical Company Profile

CRH Medical Corporation provides various products and services to gastroenterologists for the treatment of gastrointestinal diseases in the United States, Canada, and internationally. It offers CRH O'Regan system, a single use, disposable, and hemorrhoid banding technology for treating various grades of hemorrhoid.

Read More: Key terms to understand channel trading

Get a free copy of the Zacks research report on CRH Medical (CRHM)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for CRH Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CRH Medical and related companies with MarketBeat.com's FREE daily email newsletter.